When 23andMe veteran Linda Avey pitched her new start-up, We Are Curious, which focuses on integrating patient-reported symptoms and experiences, she thought she’d emphasize a condition that seemed like an easy win: menopause-associated symptoms. VCs, she reasoned, would be immediately grasp the size (and associated economics) of this market, the need to better understand the […]
Let's Get Personal
An article in the Wall Street Journal a couple of weeks ago described a disappointing development in the field called “Personalized Medicine.” For those who aren’t familiar with this term of art, it is generally used to mean the use of a patient’s specific genetic or other biologic information to match them with specific drugs that […]